HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hai-Liang Zhu Selected Research

aspernigerin

5/2006Structure and total synthesis of aspernigerin: a novel cytotoxic endophyte metabolite.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hai-Liang Zhu Research Topics

Disease

100Neoplasms (Cancer)
01/2022 - 07/2008
11Melanoma (Melanoma, Malignant)
01/2017 - 01/2012
7Infections
01/2021 - 08/2015
6Breast Neoplasms (Breast Cancer)
01/2022 - 10/2012
5Neoplasm Metastasis (Metastasis)
12/2021 - 03/2012
5Hypoxia (Hypoxemia)
10/2021 - 04/2015
4Carcinoma (Carcinomatosis)
12/2020 - 05/2006
4Stomach Ulcer (Gastric Ulcer)
08/2018 - 10/2012
3Gastritis
08/2018 - 05/2013
3Leukemia
02/2012 - 05/2007
2COVID-19
01/2022 - 12/2020
2Seizures (Absence Seizure)
12/2020 - 08/2019
2Epilepsy (Aura)
12/2020 - 08/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2020 - 01/2020
2Colonic Neoplasms (Colon Cancer)
09/2019 - 04/2019
2Carcinogenesis
01/2018 - 05/2009
2Inflammation (Inflammations)
06/2016 - 02/2016
1Pneumonia (Pneumonitis)
07/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2022
1Multiple Myeloma
01/2022
1Coronary Disease (Coronary Heart Disease)
01/2022
1Pathologic Processes
09/2021
1Thrombosis (Thrombus)
01/2020
1Diabetes Mellitus
01/2020
1Metabolic Diseases (Metabolic Disease)
01/2020
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/2019

Drug/Important Bio-Agent (IBA)

26Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 05/2009
19Biological ProductsIBA
01/2022 - 06/2011
9TubulinIBA
01/2021 - 08/2011
7UreaseIBA
01/2021 - 10/2013
7Pharmaceutical PreparationsIBA
09/2019 - 11/2012
6Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
12/2020 - 01/2016
5Oxygen (Dioxygen)IBA
10/2021 - 04/2019
5ColchicineFDA LinkGeneric
01/2021 - 08/2011
5Urea (Carbamide)FDA LinkGeneric
10/2012 - 05/2007
4EnzymesIBA
01/2022 - 01/2019
41-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2021 - 06/2020
4SulfonamidesIBA
12/2020 - 08/2013
4pyrazoleIBA
01/2020 - 01/2016
4Telomerase (Telomerase Reverse Transcriptase)IBA
06/2016 - 10/2010
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016 - 10/2012
3CurcuminIBA
01/2022 - 01/2012
3Tubulin ModulatorsIBA
01/2021 - 06/2015
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2020 - 01/2016
3NitroimidazolesIBA
01/2016 - 09/2011
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2016 - 05/2009
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2015 - 04/2012
3ResveratrolIBA
01/2012 - 06/2011
2Fluorescent Dyes (Fluorescent Probes)IBA
07/2022 - 09/2021
2ProdrugsIBA
12/2021 - 09/2011
2Glutathione (Reduced Glutathione)IBA
12/2021 - 06/2019
2Anticonvulsants (Antiepileptic Drugs)IBA
12/2020 - 08/2019
2raf KinasesIBA
09/2019 - 05/2009
2Proto-Oncogene Proteins B-rafIBA
08/2019 - 01/2017
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2019 - 11/2010
2Phosphotransferases (Kinase)IBA
01/2018 - 05/2009
2indoleIBA
01/2017 - 01/2016
2VemurafenibIBA
10/2016 - 01/2014
2coumarinIBA
01/2016 - 08/2013
2ThioureaIBA
10/2012 - 05/2009
1AnionsIBA
07/2022
1Superoxides (Superoxide)IBA
07/2022
1NaphthalimidesIBA
01/2022
1Hypochlorous Acid (Hypochlorite)IBA
01/2022
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2022
1VaccinesIBA
01/2022
1Human Serum AlbuminFDA LinkGeneric
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
12/2021
1Diphosphonates (Bisphosphonates)IBA
12/2021
1manganese dioxideIBA
11/2021
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2021
1Small Interfering RNA (siRNA)IBA
09/2021
1SulfurIBA
09/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021
1polysulfideIBA
09/2021
1HydrogenIBA
09/2021
1A-Form DNA (A-DNA)IBA
06/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021
1hydroxycamptothecinumIBA
01/2021
1Epirubicin (Ellence)FDA LinkGeneric
01/2021
1MetalsIBA
01/2021
1ThiazepinesIBA
01/2021
1homocamptothecinIBA
01/2021
1fibrin fragment D (D-dimer)IBA
12/2020
1Cyclin-Dependent Kinase 4IBA
10/2020
1Blood Glucose (Blood Sugar)IBA
01/2020
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2020
1ThrombinFDA Link
01/2020
1Tumor Biomarkers (Tumor Markers)IBA
01/2020
1Therapeutic UsesIBA
01/2020
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2019

Therapy/Procedure

33Therapeutics
12/2021 - 11/2010
7Drug Therapy (Chemotherapy)
10/2021 - 01/2017
3Precision Medicine
12/2021 - 11/2021
3Photochemotherapy (Photodynamic Therapy)
10/2021 - 06/2020
1Immunotherapy
11/2021
1Photothermal Therapy
09/2021
1Radiotherapy
01/2020
1Biological Therapy
09/2019